DUBLIN, June 2, 2016 /PRNewswire/ --
Research and Markets has announced the addition of the "Global Human Vaccine Market 2016-2020" report to their offering.
According to the Centers for Disease Control and Prevention (CDC), a vaccine is a product that stimulates a person's immune system to produce immunity to a specific disease, protecting the person from that disease. Vaccines are usually administered through needle injections, but can also be administered by mouth or sprayed into the nose.
Human vaccines are of two types: preventable human vaccines and therapeutic human vaccines. Preventable human vaccines are used both for adults and children. Pediatric human vaccines are used to immunize children against various infectious diseases such as diphtheria, influenza, hepatitis, pneumococcal diseases, and meningococcal diseases.
The report forecasts the global human vaccines market to grow at a CAGR of 11.69% during the period 2016-2020.
The report covers the present scenario and the growth prospects of the global human vaccines market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of preventable and therapeutic human vaccines.
The market is divided into the following segments based on geography:
- Americas
- APAC
- Europe
The report, Global Human Vaccine Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Companies Mentioned:
- GlaxoSmithKline
- Merck
- Pfizer
- Sanofi
- Abbott
- AstraZeneca
- Bavarian Nordic
- Baxter
- Bharat Biotech
- Bharat Immunologicals and Biologicals
- bioCSL
- Bio Med
- Crucell
- Dynavax Technologies
- Indian Immunologicals
- Janssen Pharmaceuticals
- Kaketsuken
- LG Life Sciences
- Mitsubishi Tanabe Pharma
- Lupin
- Nuron
- Novartis
- Protein Sciences Corporation
- Panacea Biotec
- Roche
- Serum Institute of India
- Shenzhen Kangtai Biological Products
- Sinovac Biotech
- S K Chemicals
- Takeda Pharmaceutical
- Valeant Pharmaceuticals
- Zydus Cadila
Report Structure:
PART 01: Executive summary
PART 02: Scope of the report
PART 03: Market research methodology
PART 04: Introduction
PART 05: Vaccine approval process
PART 06: Pipeline portfolio
PART 07: Market landscape
PART 08: Market segmentation by type of human vaccine
PART 09: Market segmentation by composition
PART 10: Market segmentation by route of administration
PART 11: Market segmentation by type of human vaccine
PART 12: Global therapeutic human vaccines market
PART 13: Global preventable human vaccines market
PART 14: Global pediatric preventable human vaccines market
PART 15: Global adult preventable human vaccines market
PART 16: Geographical segmentation
PART 17: Market drivers
PART 18: Impact of drivers
PART 19: Market challenges
PART 20: Impact of drivers and challenges
PART 21: Market trends
PART 22: Vendor landscape
PART 23: Key vendor analysis
PART 24: Appendix
PART 25: About the Author
For more information visit http://www.researchandmarkets.com/research/rj25h9/global_human
Media Contact:
Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets
Share this article